Login

Verisec's Freja Emerges as Top Choice for UK Public Sector Identity Management | Johan Henrikson , CEO & Co-founder at Verisec AB 00:10:00

Share On Facebook Share On Twitter

Johan Henrikson is the CEO & Co-founder at Verisec AB

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Network Capital Masterclass: Niel Wyma on Search Funds and Entrepreneurship
00:10:00
Clearing the Path for Healing and Reform in Policing America
00:10:00
Nick Tulloch, CEO of Voyager Life PLC, on Navigating CBD Regulations and the Power of Digital Marketing | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
THE WAY EDGE LEARNING GUIDES COMPLEX PART ASSEMBLY AND AUGMENTED REALITY | Robert J. Willett, CEO, Cognex CorpCGZF:FRA
00:00:00
Ergomed in robust shape to keep delivering - Jonathan Curtain, CFO, Ergomed
00:10:00
Inflation Trends and Global Economic Insights: Market Week in Review | McKenna Painter
00:10:00
investment vehicle to empower historically overlooked people and market|Alison Rapaport Stillman,Partner,Serena Ventures
00:10:00
Former CEO Christer Fehrling introduces new ceo David Rytter | David Rytter, CEO, Avtech Sweden AB (publ) AVT B:STO
00:10:00
CAREL CEO Francesco Nalini on the Importance of Going Public at Salone del Risparmio 2019 | Francesco Nalini, CEO of CAREL Group
00:10:00
Exploring the Potential of Copper, Zinc, and Silver Deposits in Ireland: IMC Exploration Group's Progress and Plans | Eamon O’Brien, Chairman at IMC Exploration Group PLC
00:10:00
"Brendan Caldwell Answers Key Investing Questions for Canadians"
00:10:00
Are Your Emotions or Finances in Control? Let's Talk.

© 2017 - Neuhu+